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ABSTRACT The (3-adrenergic receptor kinase is an en-
zyme, possibly analogous to rhodopsin kinase, that multiply
phosphorylates the (3-adrenergic receptor only when it is
occupied by stimulatory agonists. Since this kinase may play an
important role in mediating the process of homologous, or
agonist-specific, desensitization, we investigated the functional
consequences of receptor phosphorylation by the kinase and
possible analogies with the mechanism of action of rhodopsin
kinase. Pure hamster lung 182-adrenergic receptor, reconsti-
tuted in phospholipid vesicles, was assessed for its ability to
mediate agonist-promoted stimulation of the GTPase activity of
coreconstituted stimulatory guanine nucleotide-binding regu-
latory protein. When the receptor was phosphorylated by
partially ("350-fold) purified preparations of ,B-adrenergic
receptor kinase, as much as 80% inactivation of its functional
activity was observed. However, the use ofmore highly purified
enzyme preparations led to a dramatic decrease in the ability
of phosphorylation to inactivate the receptor such that pure
enzyme preparations (""20,000-fold purified) caused only min-
imal (""16 ± 7%) inactivation. Addition ofpure retinal arrestin
(48-kDa protein or S antigen), which is involved in enhancing
the inactivating effect of rhodopsin phosphorylation by rho-
dopsin kinase, led to partial restoration of the functional effect
of ,B-adrenergic receptor kinase-promoted phosphorylation (41
+ 3% inactivation). These results suggest the possibility that a
protein analogous to retinal arrestin may exist in other tissues
and function in concert with ,I-adrenergic receptor kinase to
regulate the activity of adenylate cyclase-coupled receptors.
Transmembrane signaling systems for converting extracellu-
lar stimuli as divergent as hormones, drugs, or photons of
light into intracellular metabolic changes have been remark-
ably conserved through evolution. Such systems generally
consist of three major components: a receptor, such as the
P-adrenergic receptor (J3AR) or the visual "light receptor"
rhodopsin; a guanine nucleotide-binding regulatory protein,
such as the stimulatory guanine nucleotide-binding regulato-
ry protein (Gs) or transducin; and an effector, such as
adenylate cyclase or cGMP phosphodiesterase (1-4). Not
only are such systems analogous, but individual components
are actually homologous proteins such as the ,BAR and
rhodopsin or Gs and transducin. Moreover, two analogous
enzymes that may function to regulate the activities of such
systems have been described. Rhodopsin kinase is a cytosolic
enzyme that phosphorylates only the light-bleached form of
rhodopsin on multiple serine and threonine residues (up to 9
mol of phosphate per mol of receptor) and is thought to be
involved in deactivating the illuminated form of rhodopsin so
that it does not continue to activate transducin (5, 6). P3AR
kinase is a ubiquitously distributed cytosolic enzyme that
phosphorylates only the agonist-occupied form of the PAR
(up to 9 mol ofphosphate per mol) (7). It is probably involved
in phosphorylating and regulating other adenylate cyclase-
coupled receptors as well (8, 9). We have proposed that PAR
kinase may mediate the phosphorylation of the P3AR that
accompanies and may cause the "homologous" or agonist-
specific form of adenylate cyclase desensitization.
Phosphorylation of rhodopsin by rhodopsin kinase only
partially explains the diminished capacity of phosphorylated
rhodopsin to activate transducin. In addition, another cyto-
solic retinal protein, variably termed 48-kDa protein, S
antigen, or arrestin, binds specifically to phosphorylated
rhodopsin and, thereby, inhibits its ability to interact with
transducin (6).
In the present studies we have investigated the functional
consequences of phosphorylation of purified mammalian
f82-adrenergic receptor with ,AR kinase by assessing the
ability of these receptors to mediate the agonist-promoted
stimulation of the GTPase activity of Gs in a reconstituted
system. Moreover, a functionally important interaction of
purified retinal arrestin with this system is documented.
METHODS
Protein Purification. ,B-Adrenergic receptor from hamster
lung was purified to >95% homogeneity by sequential affinity
chromatography and HPLC as described (10).
Gs was purified from a cholate extract of washed human
erythrocyte membranes as described (11). The preparations
used in these experiments were from step 8A in ref. 11 and
were >95% pure as judged by Coomassie blue staining of
polyacrylamide gels.
,BAR kinase was purified from bovine brain by (NH4)2SO4
precipitation of a high-speed supernatant fraction as de-
scribed (12). The precipitate was then chromatographed on
Ultrogel AcA 34, DEAE-Sephacel, CM-Fractogel, and hy-
droxylapatite. This yielded preparations in which PAR kinase
represented -=0.8% ofthe total protein after Ultrogel AcA 34,
41.5% after DEAE-Sephacel, 10-20% after CM-Fractogel,
and >90%o after hydroxylapatite.
Arrestin was purified to >90% homogeneity from bovine
retina using its reversible binding to phosphorylated rhodop-
sin (13). Some preparations were further purified to apparent
homogeneity by FPLC using a Mono Q column (13). Both
preparations gave identical results.
Phosphorylation. Purified PAR (25-50 pmol) was initially
reconstituted in soybean phosphatidylcholine vesicles as
described (7, 14). The protein-lipid pellets were resuspended
in 20-30 ,ul of 20 mM Tris HCl, pH 7.5/2 mM EDTA before
incubation with ,3AR kinase. These reaction mixtures con-
Abbreviations: p[NH]ppA, adenosine 5'-[3,By-imido]triphosphate;
WAR, f-adrenergic receptor; G., stimulatory guanine nucleotide-
binding regulatory protein.
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tained, in a total volume of 40 Al, reconstituted PAR (2-5
pmol), 20 ,M (-)-isoproterenol, and PAR kinase in 20 mM
Tris HCl, pH 7.5/2 mM EDTA/5 mM MgCl2/0.5 mM ascor-
bic acid and either 50 ,uM ATP (phosphorylated) or 50 ,M
adenosine 5'-[P,y-imido]triphosphate (p[NH]ppA) (control).
In addition, to inhibit endogenous cAMP-dependent protein
kinase present in the crude PAR kinase preparations a
peptide inhibitor of this kinase was included in most exper-
iments at a concentration of 5 ,ug/ml. This inhibitor is a
synthetic peptide comprising the 24 amino-terminal residues
of the specific cAMP-dependent protein kinase inhibitor (15,
16). In some experiments (see Fig. 1), 20 ml of cold 100 mM
NaCl/10 mM Tris HCI, pH 7.2/2 mM EDTA was added after
the incubation period. The samples were then centrifuged
(350,000 X g for 60 min), and the resultant pellets were
resuspended in 300 Al of 100 mM NaCl/10 mM Tris HCI, pH
7.2. Samples were incubated with G. before assaying for
GTPase activity. In other experiments (see Figs. 2 and 3),
following a 1-hr incubation at 300C, the samples were diluted
with 250 Al of cold 100 mM NaCl/10 mM Tris-HCI, pH 7.2.
The diluted samples containing either control or phospho-
rylated FAR were then incubated with Gs and retinal arrestin
(see Fig. 3) for 20 min on ice. Samples were then assayed for
GTPase activity. In these studies, the stoichiometry of
phosphorylation varied depending on the particular PAR
kinase preparation used. With Ultrogel AcA 34- or DEAE-
Sephacel-purified FAR kinase, only 3-4 mol ofphosphate per
mol of PAR could be obtained with a 1-hr incubation due to
the relatively lower concentration of PAR kinase in these
preparations. More concentrated PAR kinase preparations
(CM-Fractogel or hydroxylapatite) are able to maximally
phosphorylate PAR (8-9 mol of phosphate per mol) during a
1-hr incubation or less.
GTPase Assay. Samples were assayed for GTPase activity
at 300C by incubating 50 of vesicles in a total volume of 100
/l containing 10 mM Tris HCI (pH 7.8), 10 mM MgCl2, 1 mM
EDTA, bovine serum albumin at 2 mg/ml, 0.5 mM ascorbic
acid, 0.2 mM p[NH]ppA, 0.1 ,uM [y-32P]GTP, and either 100
AuM (-)-isoproterenol or 100 ,M (+)-alprenolol. Reactions
were stopped by the addition of trichloroacetic acid, and,
following centrifugation, the inorganic [32P]phosphate in the
supernatant was determined by extraction with molybdate/2-
methyl-1-propanol/benzene (17). Isoproterenol-stimulated
GTPase activity was calculated as the difference between the
activity in the presence of isoproterenol and in the presence
of alprenolol and generally represented an =3-fold stimula-
tion by the agonist.
Electrophoresis. Gel electrophoresis was performed by the
method of Laemmli (18) using 10% polyacrylamide gels.
Sample buffer consisted of 8% (wt/vol) NaDodSO4, 10O
(vol/vol) glycerol, 5% (vol/vol) 2-mercaptoethanol, 25 mM
Tris'HC1 (pH 6.5), and 0.003% bromphenol blue. After
electrophoresis, gels were immediately dried prior to auto-
radiography at -90'C.
RESULTS
Initially, partially purified preparations of PAR kinase were
used to phosphorylate the reconstituted purified OAR. These
enzyme preparations, which were -1% pure, had been
chromatographed on an Ultrogel AcA 34 column after
(NH4)2SO4 precipitation and were purified -350-fold from
the starting material (12). As shown in Fig. 1, as phosphate
was incorporated into the receptor, a progressive diminution
of the receptor-promoted activation of G, was observed. At
a stoichiometry of -3 mol of phosphate per mol of BAR, an
=80%o reduction in receptor activity was observed when
compared with the control (nonphosphorylated). This loss of
receptor function was not due to a reduced ability of the
receptor to bind agonist ligands since, as shown in Table 1,
INCUBATION TIME (MIN)
FIG. 1. Isoproterenol-promoted GTPase activity in phospholipid
vesicles containing G, and receptor phosphorylated by ,AR kinase.
Phospholipid vesicles containing purified BAR were incubated at
300C for 5, 20, or 60 min with Ultrogel AcA 34-purified BAR kinase
in a buffer of 20 mM Tris HCl (pH 7.5), 2 mM EDTA, 4 mM MgCl2,
10 ,uM (-)-isoproterenol, 4 mM sodium phosphate, 4 mM NaF, and
either 75 ,M p[NH]ppA (control) or 75 ALM ATP (phosphorylated) or
75 ,uM [y-32P]ATP (-2 cpm/fmol). Reactions were stopped by the
addition of 20 ml of cold 100 mM NaCl/10 mM TrisHCl, pH 7.2/2
mM EDTA. After centrifugation, the pellets from the [y-32P]ATP
samples were resuspended in NaDodSO4 sample buffer before
electrophoresis on a 1o polyacrylamide gel. Stoichiometries of
phosphorylation were determined as described (7, 12). Pellets from
the p[NH]ppA and ATP incubations were resuspended in 300 Al of
100 mM NaCl/10 mM Tris HCl, pH 7.2. Samples (containing -0.4
pmol of 8AR) were then incubated with -1.5 pmol of G0 for 20 min
at 40C before assaying for isoproterenol-stimulated GTPase activity.
the affinity of several ligands for binding to control and
phosphorylated receptors was not altered. The loss of func-
tion was also not due to proteolysis since, as assessed by
NaDodSO4/PAGE, the molecular weight of the receptor is
unaltered (data not shown).
While phosphorylation of the receptor by partially purified
(PAR kinase preparations was accompanied by a parallel
reduction in receptor activity, this effect was substantially
lost as the kinase was further purified. Fig. 2 presents results
obtained with PAR kinase preparations of various levels of
purity. When the enzyme preparations used for the experi-
ments shown in Fig. 1 were chromatographed on DEAE-
Sephacel columns, a further =2-fold purification occurred.
As described (12), in this step of purification PAR kinase
Table 1. Comparison of the EC" values of control and
phosphorylated BAR
EC50, nM
Agent Control Phosphorylated
(-)-Alprenolol 8.3 ± 0.6 6.8 ± 0.3
(-)-Isoproterenol 1725 ± 548 1750 ± 299
(-)-Epinephrine 6450 ± 2692 5500 ± 997
EC.5 values for the ligands were calculated from competition curve
data at a concentration of 50 pM 125I-labeled (-)-cyanopindolol and
various concentrations of agonist or antagonist. Data were analyzed
by computer modeling methods (19). The BAR used in this experi-
ment was phosphorylated by CM-Fractogel-purified PAR kinase.
The purity of the /3AR kinase preparation had no appreciable
influence on the results of such studies. The data shown are mean +
SD of two experiments.
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FIG. 2. Effect of receptor phosphorylation by various PAR
kinase preparations on inhibiting receptor-G, coupling. Phospholipid
vesicles containing purified PAR were incubated for 60 min with
Ultrogel AcA 34-purified, DEAE-Sephacel-purified, or CM-Fracto-
gel-purified 3AR kinase. The percent purity at each step is shown at
the top of the figure. Control (p[NH]ppA) and phosphorylated (ATP)
PAR preparations (-0.5 pmol) were then incubated with G, (-1.5
pmol) before assaying for isoproterenol-stimulated GTPase activity.
The results are expressed as the percent inhibition of phosphorylated
vs. control receptor preparations. The stoichiometry of phosphoryl-
ation in this particular experiment was 3-4 mol of phosphate per mol
of receptor with all PAR kinase preparations. These results are
representative of three independent experiments.
passes directly through the DEAE-Sephacel column. Such
enzyme preparations, which are about 1.5% pure, caused
only -20% inactivation of receptor-promoted GTPase activ-
ity. Additional chromatography on CM-Fractogel and hy-
droxylapatite columns produced essentially homogeneous
enzyme preparations that, while phosphorylating the recep-
tors to a comparable stoichiometry in this experiment (3-4
mol of phosphate per mol), caused only 10-15% receptor
inactivation. These results suggest that, in addition to recep-
tor phosphorylation, the participation of some other factor
that is lost during the purification of PAR kinase is required
for receptor function to be regulated.
Since it has been demonstrated (6) that inactivation of
light-promoted phosphodiesterase activity is enhanced by
binding of arrestin to phosphorylated rhodopsin, we tested
the effects of purified retinal arrestin in the PAR system. The
results are shown in Fig. 3. In the absence of arrestin, the
phosphorylated receptor stimulated G.-associated GTPase
activity to 84.4 + 6.8% (n = 5) of that obtained with the
unphosphorylated receptor. Addition of increasing amounts
of arrestin to the reconstituted j3AR/Gs/pure PAR kinase
system has no effect on receptor activity under nonphospho-
rylating conditions. Thus, the mean activity of control re-
ceptor in the presence of various levels of arrestin was 98.1
3.5% (n = 13) of the value in the absence of arrestin.
However, following the phosphorylation of PAR by ATP and
pure ,AR kinase, addition of various amounts of arrestin
leads to a progressive reduction in receptor-Gs interaction,
such that at high arrestin (arrestin/G. molar ratio, >100:1)
only 59.3 ± 2.6% (n = 9) of control activity is observed (P <
0.001). This effect was shown to be specific as it required the
simultaneous presence of,AR kinase-phosphorylated PAR,
Gs, and arrestin. Arrestin could not be replaced by bovine
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FIG. 3. Effect of retinal arrestin on inhibiting I3AR-GS coupling.
Phospholipid vesicles containing purified PAR were incubated for 60
min with purified BAR kinase (>90%). The stoichiometry of phos-
phorylation was -8 mol of phosphate per mol of receptor. Control
(p[NH]ppA) and phosphorylated (ATP) 8AR preparations ('0.4
pmol) were then incubated with purified retinal arrestin (0-1500
pmol) and pure G. (-2.4 pmol) for 20 min at 40C. Samples were then
assayed for isoproterenol-stimulated GTPase activity. The results
are data from five separate experiments. The error bars represent
means ± SEM from two to five independent experiments as shown
in parentheses; individual points are data from single experiments.
serum albumin or heat-denatured arrestin. The maximum
reduction achieved was about one-half of that observed with
the crude PAR kinase preparations (40% vs. 80%6). Thus,
addition ofpure arrestin to PAR phosphorylated by pure PAR
kinase partially restores the ability of the phosphorylation to
inactivate receptor function.
DISCUSSION
These results have important implications for understanding
the possible mechanisms by which covalent modification of
adenylate cyclase-coupled receptors may regulate their func-
tion. Phosphorylation of the PAR by partially purified prep-
arations ofPAR kinase clearly leads to receptor inactivation,
apparent as an impairment ofreceptor coupling to Gs. In clear
analogy with the retinal system for inactivating rhodopsin (6),
the functional effect ofPAR kinase appears to be significantly
enhanced by some other cytosolic factor(s) that is separated
from PAR kinase during its purification. The existence of
such a factor that may be similar to the retinal protein is
suggested, because authentic retinal arrestin can augment the
effect of /AR kinase. Possibly, with the nonretinal homolog
of this protein, even more dramatic effects on the function of
the receptor would be observed. In this connection it can also
be noted that the molar ratios of arrestin/G. (>100:1)
required for inactivation of phosphorylated PAR are signif-
icantly higher than the arrestin/transducin molar ratio
(<10:1) required for comparable effects on phosphorylated
rhodopsin (6). Since antibodies to arrestin do not identify
cross-reactive proteins in tissues other than the pineal (20),
there may be significant differences in the structure of any
such putative arrestin-like protein in nonretinal tissues.
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An obvious starting point for efforts to identify such a
protein would be side fractions from the purification ofPAR
kinase. Inasmuch as a major decrease in the receptor-
inactivating ability of PAR kinase occurs after the DEAE-
Sephacel purification step, it may be that the relevant
proteins are adsorbed to this column. The ability of any such
fraction to restore to highly purified PAR kinase preparations
receptor inactivating properties would provide an assay for
identifying and purifying the putative homolog of the retinal
arrestin.
Several studies have demonstrated that PAR phosphoryl-
ation occurs during homologous desensitization. Treatment
offrog erythrocytes with isoproterenol leads to an increase in
PAR phosphorylation from 0.6 to 1.9 mol of phosphate per
mol of receptor (21). Studies in S49 lymphoma cells (from 0.2
to 0.8 mol of phosphate per mol of receptor) and DDT1-MF2
cells (from 0.4 to 2.0 mol of phosphate per mol of receptor)
also show increased receptor phosphorylation with agonist
treatment (8, 22). These whole-cell studies suggest that
relatively low stoichiometries of phosphorylation are ob-
tained (1-2 mol of phosphate per mol of receptor) as com-
pared with in vitro phosphorylation of purified PAR by PAR
kinase (8 mol of phosphate per mol of receptor) (12). These
results are potentially explained in several ways. First, it is
possible in the whole-cell studies that during the receptor-
purification procedures, which are required for subsequent
visualization of the phosphorylated receptor on NaDodSO4/
PAGE, a significant amount of phosphate is lost due to
contaminating phosphatase activity. A second point to be
considered is that these measurements of phosphorylation
stoichiometry are only average values, i.e., they do not
provide information about individual receptor populations.
Thus an average of 2 mol of phosphate per mol of receptor
may result from receptors phosphorylated to various degrees
from 0 to 8 mol of phosphate per mol of receptor. This issue
may be approachable using techniques such as isoelectric
focusing. Another possibility is that the stoichiometry of
phosphorylation in whole cells is indeed relatively low. The
data in Fig. 1, which demonstrate that 2-3 mol of phosphate
per mol ofPAR inhibits its interaction with G. -80%, suggest
that a high stoichiometry is not required for uncoupling.
Additional studies will be necessary to determine the corre-
lation between phosphorylation stoichometry and desensiti-
zation.
The concerted effects ofPAR kinase and retinal arrestin on
the function of the PAR further extend the growing list of
analogies between the visual and hormonal membrane sig-
naling systems. These analogies must now be extended to
include the mechanisms of regulation of receptor function at
the molecular level.
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